HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sheffield, H. G. Articles by Melton, M. L. Search for Related Content PubMed PubMed Citation Articles by Sheffield, H. G. Articles by Melton, M. L.

Effects of Pyrimethamine and Sulfadiazine on the Intestinal Development of Toxoplasma Gondii in Cats

Treatment with combined pyrimethamine and sulfadiazine prolonged the prepatent period and shortened the patent period of cyst-induced toxoplasmosis in cats. Oocyst excretion was inhibited in 3 of 4 cats treated intramuscularly with 2 mg/kg body weight pyrimethamine and 100 mg/kg body weight sulfadiazine but not in 4 cats treated with one-half that dosage. Treatment with 2.2 mg/kg body weight pyrimethamine and 132 mg/kg body weight sulfadiazine mixed in cat food did not inhibit oocyst production but prevented antibody formation. No parasites were found upon histological examination of intramuscularly treated cats on days 3, 5, and 7 after infection. Infection with Toxoplasma gondii induced immunity to an oocyst-producing reinfection in both control and treated cats.

Accepted for publication October 25, 1975.